As part of the plan, Amazon has agreed to purchase 100,000 electric delivery vans from vehicle manufacturer Rivian.Technologyread more
The plan will allow Medicare to negotiate lower prices on as many as 250 drugs and also apply those discounts to private health plans.Health and Scienceread more
President Donald Trump on Thursday filed a lawsuit against Manhattan District Attorney Cyrus Vance Jr. and his longtime accounting firm Mazars.Politicsread more
The Democratic-held House plans to move forward with a bill to fund the government through Nov. 21 and avoid another government shutdown.Politicsread more
GM's usage of temporary workers, potential closure of plants and health care contributions remain major sticking points, according to people familiar with the talks.Autosread more
The U.S. economy will have a tough time at the start of 2020, says the head of one of the largest bond managers in the world.Delivering Alpharead more
A new Hollister store is coming later this month to New York, right down the block from Macy's, Target and Victoria's Secret in the busy Herald Square shopping district.Retailread more
Newly public ride-sharing companies Uber and Lyft have tumbled 25% since their initial public offerings, but Light Street's Glen Kacher still believes there's a path for...Delivering Alpharead more
The Federal Reserve has calmed the overnight funding market and brought its fed funds rate back in line with its target.Market Insiderread more
The PSA features kids in what initially appears to be a cheerful spot. But it becomes darker as children show how their "back to school" products help in the context of a...Politicsread more
Hasbro, Inc.: "It turns out, a la what happened with Nike and what happened with Under Armour, it takes a little while longer to clear all that inventory from the system and that's what's happening with Toys R Us and Hasbro. I beg you to hold this stock. [CEO] Brian [Goldner] has never let us down and he won't do it this time."
Nektar Therapeutics: "That was a stunning reversal. It was paired with that Bristol-Myers [Squibb] drug. I was really surprised, but you know what? Down here, I'm not going to say sell it. Everybody already has."
The Blackstone Group L.P.: "If you've got that [three-to-five-year] time frame, that's great because the yield's good and if you keep reinvesting I think you'll do absolutely fine. It's a good one."
Corning: "It's a weak hold. It doesn't have any real earnings momentum. It's in that same group with OLED. There's just so much turmoil in that group. I'm going to have to say pass."
Banco Santander: "Banco Santander is not so good right now. I don't like the turmoil in Spain. I don't like the changing government. I'm going to have to say you've got to take a pass. I mean, there was a great long-term run there, but Spain is problematic."
Edwards Lifesciences Corporation: "It's funny you ask because Medtronic had a big meeting today and Medtronic is really their rival. I wish [Edwards] had a bigger product line, but they still have the hot product which means they're still going to beat the numbers which means the stock is still going to go higher."
U.S. Bancorp: "I don't need any more financials than we already have on this show. [I'm] recommending J.P. Morgan, recommending Citi, recommending Goldman, all owned by [my] www.ActionAlertsPlus.com charitable trust. I'm not going to get another one. Too darned hard."
J.Jill, Inc.: "Look, it was a good quarter. Do I think it's a great secular growth story? No. Could it go up another buck and a half? Yes. Is that what I'm looking for? No. There you go."
Disclosure: Cramer's charitable trust owns shares of J.P. Morgan, Citigroup and Goldman Sachs.